Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta-Lactams Dosing In Pneumonia in ICU in Patients Treated by Continuous Renal Replacement Therapy

NCT03897582 is registered in ClinicalTrials.gov with Centre Hospitalier de Valenciennes as lead sponsor.

NCT NCT03897582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03897582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta-Lactams Dosing In Pneumonia in ICU in Patients Treated by Continuous Renal Replacement Therapy
Lead sponsor
Centre Hospitalier de Valenciennes
Phase
Observational
Overall status
Unknown status
Start date
February 22, 2019
Completion date
May 31, 2026
Enrollment
65 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic, beta-lactam, continuous renal replacement therapy, pneumonia